VOLTAREN RAPID 50 diclofenac potassium 50mg tablet blister pack

Quốc gia: Úc

Ngôn ngữ: Tiếng Anh

Nguồn: Department of Health (Therapeutic Goods Administration)

Thành phần hoạt chất:

diclofenac potassium, Quantity: 50 mg

Sẵn có từ:

Novartis Pharmaceuticals Australia Pty Ltd

Dạng dược phẩm:

Tablet, sugar coated

Thành phần:

Excipient Ingredients: colloidal anhydrous silica; calcium phosphate; magnesium stearate; maize starch; povidone; sodium starch glycollate; microcrystalline cellulose; iron oxide red; macrogol 8000; sucrose; purified talc; titanium dioxide

Tuyến hành chính:

Oral

Các đơn vị trong gói:

4,5,6,10,20 and 30 tablets

Loại thuốc theo toa:

(S4) Prescription Only Medicine

Chỉ dẫn điều trị:

Inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. Relief of acute or chronic pain states in which there is an inflammatory component. Symptomatic treatment of primary dysmenorrhoea

Tóm tắt sản phẩm:

Visual Identification: Reddish brown, round, biconvex, sugar coated tablets, diameter approx.8.8mm, thickness approx.5.2mm.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Tình trạng ủy quyền:

Registered

Ngày ủy quyền:

1993-05-27

Tờ rơi thông tin

VOLTAREN
® RAPID
_diclofenac potassium_
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Voltaren Rapid.
It does not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
The information in this leaflet was
last updated on the date listed on the
final page. More recent information
on the medicine may be available.
YOU SHOULD ENSURE THAT YOU SPEAK
TO YOUR PHARMACIST OR DOCTOR TO
OBTAIN THE MOST UP TO DATE
INFORMATION ON THE MEDICINE. YOU
CAN ALSO DOWNLOAD THE MOST UP TO
DATE LEAFLET FROM
WWW.NOVARTIS.COM.AU.
Those updates may contain important
information about the medicine and
its use of which you should be aware.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you taking this medicine
against the benefits they expect it
will provide.
IF YOU HAVE ANY CONCERNS ABOUT THIS
MEDICINE, ASK YOUR DOCTOR OR
PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT VOLTAREN RAPID
IS USED FOR
Voltaren Rapid belongs to a group of
medicines called non-steroidal anti-
inflammatory drugs (NSAID). It
relieves pain and reduces
inflammation (swelling and redness).
It is used for short-term treatment of
the following conditions:
•
migraine headaches and it may
also relieve the accompanying
symptoms, such as nausea and
vomiting, which you sometimes
experience when you have a
migraine
•
relief of menstrual cramps (period
pain).
•
short-term treatment (up to 1
week) of other painful conditions
where swelling is a problem such
as back or joint pain, dental pain,
muscle strains or sprains and
tendonitis (e.g. tennis elbow).
Voltaren Rapid can relieve the
symptoms of pain and inflammation
but it will not cure your condition.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY THIS MEDICINE
HAS BEEN PRESCRIBED FOR YOU.
Your doctor may have prescribed it
for another purpose.
Voltaren Rapid is only available with
a doctor's prescription. It is not
addictive.
There is not eno

Đặc tính sản phẩm

1
AUSTRALIAN PI – VOLTAREN
® RAPID (DICLOFENAC POTASSIUM)
TABLETS
1
NAME OF THE MEDICINE
Active ingredient: Diclofenac Potassium
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Voltaren Rapid tablets contain 50 mg of diclofenac potassium.
Diclofenac potassium is a white or slightly yellowish, crystalline
powder, slightly hygroscopic,
sparingly soluble in water, freely soluble in methanol, soluble in
alcohol, slightly soluble in acetone.
EXCIPIENTS: Each diclofenac potassium 50 mg tablet contains 5.8 mg of
potassium.
For the full list of excipients, see section 6.1 ‘LIST OF
EXCIPIENTS’.
3
PHARMACEUTICAL FORM
Tablets (reddish-brown, round, biconvex sugar-coated tablets).
4
CLINICAL PARTICULARS
4.1
T
HERAPEUTIC INDICATIONS
•
As short-term treatment (up to one week) for the relief of acute pain
states in which there is
an inflammatory component.
•
Treatment of acute migraine attacks (with or without aura)
•
Symptomatic treatment of primary dysmenorrhoea.
4.2
D
OSE AND METHOD OF ADMINISTRATION
Pregnancy: see Section 4.3 CONTRAINDICATIONS and Section 4.6
FERTILITY, PREGNANCY and
LACTATION.
After assessing the risk/benefit ratio in each individual patient, the
lowest effective dose for the
shortest possible duration should be used. Adverse effects may be
minimized by using the lowest
effective dose for the shortest duration necessary to control symptoms
(see section 4.4 ‘SPECIAL
WARNINGS AND PRECAUTIONS’). Patients on long term treatment should
be reviewed regularly with
regards to efficacy, risk factors and ongoing need for treatment.
The tablets should be swallowed whole with liquid, preferably before
meals, and must not be
divided or chewed.
2
DOSE
Adults
ACUTE PAIN STATES WITH AN INFLAMMATORY COMPONENT
As a rule, the initial daily dosage for adults is 100 to 150 mg. In
milder cases, as well as for children
over 14 years of age, 75 to 100 mg daily is usually sufficient. The
total daily dosage should generally
be prescribed in 2 or 3 fractional doses. Treatment is to continue for
a maximum of 7 days. If th